Insulet
PODD
474 hedge funds and large institutions have $18.6B invested in Insulet in 2021 Q4 according to their latest regulatory filings, with 91 funds opening new positions, 167 increasing their positions, 147 reducing their positions, and 43 closing their positions.
112% more first-time investments, than exits
New positions opened: 91 | Existing positions closed: 43
44% more call options, than puts
Call options by funds: $64.1M | Put options by funds: $44.5M
14% more repeat investments, than reductions
Existing positions increased: 167 | Existing positions reduced: 147
10% more funds holding
Funds holding: 432 → 474 (+42)
0.29% more ownership
Funds ownership: 101.38% → 101.67% (+0.29%)
6% less capital invested
Capital invested by funds: $19.8B → $18.6B (-$1.2B)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$168M |
| 2 |
BlackRock
New York
|
+$156M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$154M |
| 4 |
DCP
D1 Capital Partners
New York
|
+$107M |
| 5 |
ClearBridge Investments
New York
|
+$96.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$257M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
-$218M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$125M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$97.2M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$57.2M |
PODD Hedge Fund Activity: Q4 2021 in Review
474 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q4 2021, worth a combined $18.6B — down 6% from $19.8B a quarter earlier.
Buyers outnumbered sellers: 91 funds opened new PODD positions and 43 closed out — a net gain of 48 holders — while 167 added to existing stakes and 147 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $168M. The largest seller was Wells Fargo, cutting an estimated $257M.
- 474 institutional investors held Insulet (PODD) as of Q4 2021, up from 432 in Q3 2021.
- Funds reported $18.6B of Insulet stock for Q4 2021, down 6% quarter-over-quarter.
- 91 funds opened new Insulet positions in Q4 2021 and 43 closed out, a net change of +48 holders.
- The largest Insulet buyer in Q4 2021 was Capital Research Global Investors, an estimated $168M added.
- The largest Insulet seller in Q4 2021 was Wells Fargo, an estimated $257M sold.
Based on aggregated 13F filings for Q4 2021.